Search Results - "Öztürk, Hacer Berna"

Refine Results
  1. 1

    Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect by Tığlıoğlu, Mesut, Tığlıoğlu, Pınar, Yıldız, Abdulkerim, Reis Aras, Merih, Sağlam, Buğra, Afacan Öztürk, Hacer Berna, Adabağ, Ayşegül, Albayrak, Murat

    “…What is known and objective Primary myelofibrosis (PMF) is characterized by myeloid cell proliferation and prominent bone marrow fibrosis. Ruxolitinib, a…”
    Get full text
    Journal Article
  2. 2

    Infections in patients with lymphoma: An analysis of incidence, relationship and risk factors by Yıldız, Abdulkerim, Albayrak, Murat, Pala, Çiğdem, Şahin, Osman, Afacan Öztürk, Hacer Berna, Güneş, Gürsel, Maral, Senem, Okutan, Harika

    “…Bacterial infections and febrile neutropenia (FN) are major causes of morbidity and mortality in patients with hematological malignancy. The aim of this study…”
    Get full text
    Journal Article
  3. 3

    Absolute lymphocyte count is a predictor of outcome after splenectomy for immune thrombocytopenia by Yildiz, Abdulkerim, Albayrak, Murat, Pala, Cigdem, Sahin, Osman, Kus, Arif, Maral, Senem, Comert, Pinar, Ozturk, Hacer Berna Afacan

    Published in Gulhane Medical Journal (01-06-2020)
    “…Aims: Splenectomy is still the standard salvage therapy in immune thrombocytopenia (ITP) cases refractory to corticosteroid therapy. The aim of this study was…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A first time report on the coocurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment by Afacan Öztürk, Hacer Berna, Albayrak, Murat, Pala Öztürk, Çiğdem, Yıldız, Abdulkerim, Maral, Senem, Önder, Evrim

    Published in Journal of oncology pharmacy practice (01-10-2019)
    “…Sarcoidosis is known to be associated with higher incidence of solid tumors and hematological malignancies. ALK(−) CD30(+) anaplastic large cell lymphoma is a…”
    Get full text
    Journal Article
  6. 6

    Effect of Gibberellic Acid on the Levels of Tumor Necrosis Factor-α, Interleukin-4 and Interleukin-10 in Rats by AFACAN ÖZTÜRK, Hacer Berna, ERİN, Nuray, BALCI, Mustafa Kemal

    “…Objective: Gibberellic acid is a plant growth factor. Several studies have demonstrated the effect of gibberellic acid on tumor development. Tumor necrosis…”
    Get full text
    Journal Article
  7. 7

    Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis by Tığlıoğlu, Mesut, Albayrak, Murat, Doğan, Servihan, Yılmaz, Fatma, Akyol, Pınar, Sağlam, Buğra, Reis Aras, Merih, Yıldız, Abdulkerim, Afacan Öztürk, Hacer Berna, Dilek, İmdat

    Published in Leukemia & lymphoma (19-09-2021)
    “…There are only a few predictive markers that can truly aid therapy decisions in patients with acute myeloid leukemia (AML). The current study aimed to examine…”
    Get full text
    Journal Article
  8. 8

    The outcome of COVID-19 in patients with hematological malignancy by Tığlıoğlu, Pınar, Albayrak, Murat, Tığlıoğlu, Mesut, Öztürk, Hacer Berna Afacan, Aras, Merih Reis, Sağlam, Buğra, Maral, Senem

    “…Summary Objective The aim of this study was to examine the effect of coronavirus disease 2019 (COVID-19) on the malignancy-related clinical course and overall…”
    Get full text
    Journal Article
  9. 9

    Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment by Yılmaz, Fatma, Albayrak, Murat, Tığlıoğlu, Pınar, Tığlıoğlu, Mesut, Sağlam, Buğra, Reis Aras, Merih, Maral, Senem, Afacan Öztürk, Hacer Berna

    Published in Journal of oncology pharmacy practice (01-04-2022)
    “…Introduction Imatinib is generally well tolerated by patients. The most common ophthalmic side effects are eyelid edema and periorbital edema. Other side…”
    Get full text
    Journal Article
  10. 10
  11. 11

    An acute transverse myelitis attack after autologous stem cell transplantation: A rare case by Cömert, Pınar, Albayrak, Murat, Yıldız, Abdulkerim, Şahin, Osman, Öztürk, Çiğdem Pala, Maral, Senem, Güneş, Gürsel, Afacan Öztürk, Hacer Berna, Sağlam, Buğra

    Published in Transfusion and apheresis science (01-06-2019)
    “…Transverse myelitis is a quite rare complication of hematopoietic stem cell transplantation. The case is here reported of a 49 year old male with diffuse large…”
    Get full text
    Journal Article
  12. 12

    Anorectal Pathologies in the Course of Acute Leukaemias; Predictive Parameters by Yilmaz, Fatma, Saglam, Bugra, Gorduk, Ufuk, Kalan, Ugur, Ozturk, Hacer Berna Afacan, Gunes, Ahmet Kursad, Albayrak, Murat

    “…Patients with leukaemia are exposed to infections as long as they are neutropenic. During this period, anorectal pathologies are among the common foci of…”
    Get full text
    Journal Article
  13. 13

    Rare aggressive natural killer cell leukemia presented with leukopenia and disseminated intravascular coagulation—a diagnostic challenge by Yıldız, Abdulkerim, Şahin, Osman, Öztürk, Çiğdem Pala, Öztürk, Hacer Berna Afacan, Maral, Senem, Albayrak, Murat

    Published in Journal of hematopathology (01-03-2018)
    “…Aggressive natural killer cell leukemia/lymphoma (ANKL) is a rare and aggressive malignancy of natural killer (NK) cells. It is now regarded as a distinct…”
    Get full text
    Journal Article
  14. 14

    Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients? by REİS ARAS, Merih, AFACAN ÖZTÜRK, Hacer Berna, YILMAZ, Fatma, MALKAN, Ümit Yavuz, GÜNEŞ, Ahmet Kürşad, ALBAYRAK, Murat

    Published in Hitit medical journal (10-10-2023)
    “…Objective: The systemic immune inflammation index has been considered a novel prognostic biomarker in several malignant tumors. The aim of the current study…”
    Get full text
    Journal Article
  15. 15

    THE RELATIONSHIP BETWEEN FERRITIN LEVEL AND THROMBOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA by Buğra Sağlam, Murat Albayrak, Abdulkerim Yıldız, Pınar Tıplıoğlu, Mesut Tığlıoğlu, Merih Reis Aras, Fatma Yılmaz, Hacer Berna Afacan Öztürk

    Published in Hematology, Transfusion and Cell Therapy (01-10-2022)
    “…Objective: Cancer is a well-known condition associated with its treatment and follow-up and increases the risk of thrombosis. As with solid tumors, the risk of…”
    Get full text
    Journal Article
  16. 16

    Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma by Cömert, Pınar, Yıldız, Abdulkerim, Yıldırım, Murat, Afacan Öztürk, Hacer Berna, Pala, Çiğdem, Albayrak, Murat, Aylı, Meltem

    “…Low-grade Nonhodgkin lymphoma (LG-NHL) is characterized by indolent clinical course, which consist of marginal zone lymphoma (MZL), follicular lymphoma (FL),…”
    Get full text
    Journal Article
  17. 17

    A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA by Fatma YILMAZ, Murat ALBAYRAK, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Merih REİS ARAS, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: Pellagra is a systemic disease caused by a deficiency of vitamin B3 .A 19-year-old male patient, who was diagnosed with Burkitt's lymphoma was…”
    Get full text
    Journal Article
  18. 18

    A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA by Pınar Tığlıoğlu, Mesut Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk, Murat Albayrak

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: We wanted to present our patient who was diagnosed with NK/T cell type PTLD after kidney transplantation, to contribute to the…”
    Get full text
    Journal Article
  19. 19

    CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER by Mesut Tığlıoğlu, Pınar Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk, Murat Albayrak

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: In this article, we wanted to present our case in which we detected SMZL during examining for defects in coagulation tests and correlated the PT…”
    Get full text
    Journal Article
  20. 20

    A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA by Buğra Sağlam, Murat Albayrak, Hacer Berna Afacan Öztürk, Merih Reis Aras, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Fatma Yılmaz, Senem Maral

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: Congenital dyserythropoietic anemia is a group of diseases characterized by ineffective erythropoiesis and multinuclear erythroblasts, mostly…”
    Get full text
    Journal Article